Severe preeclampsia | Mild/moderate preeclampsia | No preeclampsia | Severe vs. no preeclampsia | Mild/moderate vs. no preeclampsia | Overall | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome variable | n | n | n | p-valuea) | p-valuea) | p-valueb) | ||||||
FU1 variables | ||||||||||||
Allergic rhinoconjunctivitis, n (%) | 54 | 19 | (35.2) | 161 | 36 | (22.4) | 371 | 71 | (19.1) | 0.018 | 0.822 | 0.015 |
Atopic dermatitis, n (%) | 54 | 15 | (27.8) | 163 | 37 | (22.7) | 369 | 92 | (24.9) | 1.476 | 1.172 | 1.000 |
Asthma, n (%) | 53 | 9 | (17.0) | 161 | 14 | (8.7) | 366 | 30 | (8.2) | 0.092 | 1.730 | 0.100 |
FU2 variables | ||||||||||||
Allergic sensitization, n (%) | 39 | 15 | (38.5) | 112 | 40 | (36.3) | 230 | 72 | (31.3) | 0.918 | 0.924 | 0.296 |
High level allergic sensitization, n (%)c) | 39 | 15 | (38.5) | 112 | 28 | (25.0) | 230 | 50 | (21.7) | 0.056 | 1.166 | 0.042 |
Current asthma, n (%) | 46 | 6 | (13.0) | 123 | 12 | (9.8) | 279 | 19 | (6.8) | 0.454 | 0.630 | 0.126 |
FEV1%, mean, 95% CI | 45 | 89.7 | (87.0, 92.5) | 126 | 91.0 | (89.0, 93.0) | 272 | 91.1 | (90.0, 92.2) | 1.000 | 1.000 | 0.682 |
FVC%, mean, 95% CI | 45 | 99.2 | (95.5, 102.8) | 126 | 100.0 | (97.7, 102.3) | 272 | 101.1 | (99.8, 102.4) | 0.965 | 1.000 | 0.489 |
FEV1/FVC, mean, 95% CI | 45 | 84.6 | (82.7, 86.5) | 126 | 85.3 | (83.9, 86.6) | 272 | 84.9 | (84.1, 85.7) | 1.000 | 1.000 | 0.482 |
FEF25–75%, mean, 95% CI | 45 | 84.9 | (79.4, 90.3) | 126 | 89.6 | (85.9, 93.4) | 272 | 87.4 | (85.1, 89.6) | 1.000 | 0.827 | 0.317 |
FEF25–75/FVC, mean, 95% CI | 45 | 54.5 | (50.0, 59.0) | 126 | 57.3 | (54.7, 59.9) | 272 | 55.7 | (54.1, 57.4) | 1.000 | 0.906 | 0.429 |